Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Small bowel ulcers and hypoproteinemia, differential diagnosis beyond inflamatory bowel disease
Publication Year: 2024 Source: Rev Esp Enferm Dig PMID: 39530556 DOI: 10.17235/reed.2024.10859/2024
Protein-losing enteropathy is a relatively uncommon syndrome characterized by excessive loss of proteins into the intestinal lumen. It can be caused by various etiologies. Inflammatory bowel disease (IBD) is the first condition we think of when we meet a patient with intestinal ulcers and hypoproteinemia. However, there are many other …
Clinical-histological correlation of various symptoms in the diagnosis of pediatric Crohn's disease
Publication Year: 2024 Source: Rev Esp Enferm Dig PMID: 39530559 DOI: 10.17235/reed.2024.10861/2024
Crohn's disease (CD) is a relapsing-remitting inflammatory bowel disease (IBD) affecting the gastrointestinal tract. Its symptoms are nonspecific, with weight loss, diarrhea, and abdominal pain being classic, though their diagnostic utility is controversial (2). We evaluated the clinical-pathological association of different symptoms in CD through an analytical study of patients …
Broadening perspectives in the treatment of chronic pouchitis
Publication Year: 2024 Source: Rev Esp Enferm Dig PMID: 39530569
No Abstract
Looking Inside of the Intestinal Permeability Regulation by Protein-Derivatives from Bovine Milk
Publication Year: 2024 Source: Mol Nutr Food Res PMID: 39530631 DOI: 10.1002/mnfr.202400384
The prime function of the epithelium is to regulate the intestinal permeability; the latter is a quantitative parameter that refers to the measurement of the rate of passage of solutes through the epithelial monolayer. Function of epithelial monolayer depends on the expression of protein complexes known as tight junction proteins; …
Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study
Publication Year: 2024 Source: J Patient Rep Outcomes PMID: 39531103
No Abstract
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective
Publication Year: 2024 Source: PLoS One PMID: 39531466 DOI: 10.1371/journal.pone.0312603
BACKGROUND: The Saudi Food and Drug Authority (SFDA) has approved the subcutaneous (SC) administration of infliximab, presenting a more convenient alternative with reduced outpatient visits and diminished expenses compared to the intravenous (IV) administration. However, the financial implications of this formulation have not been examined from the perspective of Saudi …
Low Rates of Short-Term Anastomotic Complications After Kono-S versus Side-to-Side Stapled Anastomosis
Publication Year: 2024 Source: J Surg Res PMID: 39531983
No Abstract
The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis
Publication Year: 2024 Source: BMC Gastroenterol PMID: 39533176 DOI: 10.1186/s12876-024-03480-9
BACKGROUND: Since 2015, an infliximab biosimilar, CT-P13, has been approved for commercial use in many countries, easing the economic burden borne by society and patients. Many clinical trials investigating CT-P13 for the treatment of IBD have been conducted and reported that it may be a substitute for infliximab. However, the …
Comprehensive analysis of psychological symptoms and quality of life in early patients with IBD: a multicenter study from China
Publication Year: 2024 Source: BMC Psychiatry PMID: 39533191 DOI: 10.1186/s12888-024-06247-4
OBJECTIVE: To investigate the prevalence and risk factors of psychological symptoms and quality of life (QoL) in early patients with inflammatory bowel disease (IBD). METHODS: From September 2021 to May 2022, a unified questionnaire was developed to collect clinical data from early patients with IBD from 42 tertiary care hospitals. …
7-hydroxycoumarin ameliorates ulcerative colitis in mice by inhibiting the MAPK pathway and alleviating gut microbiota dysbiosis
Publication Year: 2024 Source: BMC Gastroenterol PMID: 39533196
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide